The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective pooled analysis of six phase III trials investigating duration of adjuvant (adjuv) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with stage III colon cancer (CC): The IDEA (International Duration Evaluation of Adjuvant chemotherapy) collaboration.
 
Qian Shi
No Relationships to Disclose
 
Alberto F. Sobrero
No Relationships to Disclose
 
Anthony Frank Shields
Employment - Benchling (I)
Stock and Other Ownership Interests - Benchling (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Endocyte; GE Healthcare; Merck; Merrimack; Personal Genome Diagnostics; Siemens Healthcare Diagnostics; Taiho Pharmaceutical
Speakers' Bureau - GE Healthcare
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Eisai; H3 Biomedicine; Inovio Pharmaceuticals; Karyopharm Therapeutics; Merrimack; Novartis; OncoMed; Plexxikon; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Caris Life Sciences; Endocyte; GE Healthcare; Merrimack
 
Takayuki Yoshino
Research Funding - Boehringer Ingelheim (Inst); GlaxoSmithKline K.K. (Inst)
 
James Paul
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; Baxalta; Celgene; Lilly; Merck KGaA; Roche; SERVIER
Speakers' Bureau - Amgen; Baxalta; Lilly; Merck; Roche/Genentech; Sanofi; SERVIER
 
Ioannis Sougklakos
Consulting or Advisory Role - Roche
Speakers' Bureau - Sanofi
Research Funding - Amgen
Travel, Accommodations, Expenses - Amgen; Merck Serono
 
Rachel Kerr
No Relationships to Disclose
 
Roberto Labianca
No Relationships to Disclose
 
Jeffrey A. Meyerhardt
Research Funding - Biothera (Inst)
 
Franck Bonnetain
No Relationships to Disclose
 
Toshiaki Watanabe
Honoraria - Abbvie; Ajinomoto; AMCo; AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Covidien; Fujirebio Diagnostics; Intuitive Surgical; JIMRO; Johnson & Johnson; Kaken Pharmaceutical; Kyowa Hakko Kirin; MC Medical; Merck Serono; Mitsubishi Tanabe Pharma; Olympus; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - Bayer; Taiho Pharmaceutical
Research Funding - Ajinomoto; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kaken Pharmaceutical; kyorin; Kyowa Hakko Kirin; Merck Serono; Mitsubishi Chemical Group Science and Technology Research Center; Mitsubishi Tanabe Pharma; Miyarisan Pharmaceutical; Otsuka; Shionogi; Taiho Pharmaceutical; Taisho Toyama Pharma; Takeda; Toyama Chemical Co; Tsumura & Co.; Yakult Pharmaceutical
 
Ioannis Boukovinas
No Relationships to Disclose
 
Lindsay A. Renfro
No Relationships to Disclose
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Donna Niedzwiecki
No Relationships to Disclose
 
Valter Torri
No Relationships to Disclose
 
Thierry Andre
Honoraria - Amgen; Baxter; BAYER; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD Oncology; Novartis; Roche/Genentech; Sanofi; SERVIER; Xbiotech
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche/Genentech
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
Timothy Iveson
No Relationships to Disclose